APLS
Apellis Pharmaceuticals Inc.
Company Overview
| Mkt Cap | $3.80B | Price | $20.69 |
| Volume | 3.73M | Change | -3.63% |
| P/E Ratio | -19.2 | Open | $21.25 |
| Revenue | $781.4M | Prev Close | $21.47 |
| Net Income | $-197.9M | 52W Range | $16.10 - $35.72 |
| Div Yield | N/A | Target | $36.94 |
| Overall | 45 | Value | 40 |
| Quality | 50 | Technical | 45 |
No chart data available
Stock Overview
Updated DailyApellis Pharmaceuticals Inc. (APLS) is a leading Healthcare company in the Biotechnology industry, currently trading at $20.69 with a market capitalization of $3.80 billion. The stock is in the lower portion of its trading range, demonstrating average quality indicators with a MarketXLS quality score of 50.
Today's trading session shows APLS with a volume of 3.73 million shares. The stock opened down 1.05% from yesterday's close of $21.47. Current analyst estimates project earnings of $-0.33 per share for this year, with next year targeting $-1.09.
APLS demonstrates weak technical indicators based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for APLS include below-average investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 78.5%. The stock shows elevated valuation levels based on valuation analysis.
Analysis generated on November 4, 2025 at 02:30 PM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | APLS | $20.69 | -3.6% | 3.73M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Apellis Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW